Natural Product: NPC115899

Natural Product IDNPC115899
Common Name
?
The InCHIKey will be temporarily assigned as the "Common Name" if no IUPAC name or alternative short name is available.
(E/Z)-29-Hydroxystelliferin A
IUPAC Name [(3Z,3aS,5aR,6S,7S,9aR,9bS)-3-[(3E,5E,7S)-7-hydroxy-6,10-dimethylundeca-3,5,9-trien-2-ylidene]-6-(hydroxymethyl)-3a,6,9a-trimethyl-2-oxo-1,4,5,5a,7,8,9,9b-octahydrocyclopenta[a]naphthalen-7-yl] acetate
Synonyms (E/Z)-29-Hydroxystelliferin A
Synthetic Gene Cluster n.a.
ChEMBL Identifier CHEMBL474075
PubChem CID 10720560
Chemical Classification
  • CHEMONTID:0000000 [Organic compounds]
    • [CHEMONTID:0000012] Lipids and lipid-like molecules
      • [CHEMONTID:0000259] Prenol lipids
        • [CHEMONTID:0001553] Triterpenoids

The Chemical Classification was calculated by Classyfire, a software for chemical taxonomy calculation. Reference: DOI:10.1186/s13321-016-0174-y.

  Chemical Representations

Standard InCHIKey QDIPGNADJXRSEJ-BLOHMGETSA-N
Standard InCHI InChI=1S/C32H48O5/c1-20(2)12-13-24(35)21(3)10-9-11-22(4)29-25(36)18-27-30(6)17-15-28(37-23(5)34)32(8,19-33)26(30)14-16-31(27,29)7/h9-12,24,26-28,33,35H,13-19H2,1-8H3/b11-9+,21-10+,29-22+/t24-,26+,27-,28-,30-,31-,32+/m0/s1
SMILES CC(=CC[C@@H](/C(=C/C=C/C(=C/1C(=O)C[C@H]2[C@@]3(C)CC[C@@H]([C@](C)(CO)[C@@H]3CC[C@]12C)OC(=O)C)/C)/C)O)C

  Calculated Properties

Physi-Chem Properties

Molecular Weight:   512.35 Volume:   564.491
?
Van der Waals volume.
Dense:   0.908 LogP:   3.855
?
The logarithm of the n-octanol/water distribution coefficients.
logD7.4:   3.76
?
The logarithm of the n-octanol/water distribution coefficient at pH=7.4.
LogS:   -4.558
?
The logarithm of aqueous solubility value.
Rotatable Bonds:   8.0 Rigid Bonds:   21.0
TPSA:   83.83
?
Topological Polar Surface Area.
H-Bond Acceptor:   5.0
H-Bond Donor:   2.0 Rings:   3.0
Heavy Atoms:   5.0

MedChem Properties

QED Drug-Likeness Score:   0.182 GASA:   1.0
?
GASA represents the probability of being difficult to synthesize, ranging from 0 to 1.
Synthetic Accessibility Score:   4.99 Fsp3:   0.688
MCE-18:   67.407
?
MCE-18 stands for medicinal chemistry evolution.MCE-18≥45 is considered a suitable value.
Lipinski Rule-of-5:   Rejected
Pfizer Rule:   Rejected GSK Rule:   Accepted
Golden Triangle Rule:   Accepted BMS Rule:   1
Chelating Alert:   0 PAINS Alert:   0
Colloidal aggregators:   0.727 Fluc inhibitor:   0.008
?
The fluc inhibitor value is the probability of being fLuc inhibitors, within the range of 0 to 1.
Blue fluorescence:   0.069
?
The blue fluorescence value is the probability of being blue fluorescence, within the range of 0 to 1
Green fluorescence:   0.005
?
The green fluorescence value is the probability of being green fluorescence, within the range of 0 to 1
Reactive compounds:   0.556 Promiscuous compounds:   0.471

ADMET Properties (ADMETlab3.0)

ADMET: Absorption

Caco-2 Permeability:   -5.075 MDCK Permeability:   -4.848
Pgp-inhibitor:   0.027 Pgp-substrate:   0.747
PAMPA:   0.956
?
The experimental data for Peff was logarithmically transformed (logPeff). Molecules with log Peff values below 2.0 were classified as low-permeability (Category 0), while those with log Peff values exceeding 2.5 were classified as high-permeability (Category 1).
Human Intestinal Absorption (HIA):   0.0
20% Bioavailability (F20%):   0.013 30% Bioavailability (F30%):   0.083
50% Bioavailability (F50%):   0.991

ADMET: Distribution

Blood-Brain-Barrier Penetration (BBB):   0.0 MRP1:   0.966
Plasma Protein Binding (PPB):   83.293% Volume Distribution (VD):   0.079
Fu: 14.567%
?
The fraction unbound in plasms.
OATP1B1 inhibitor:   0.955
OATP1B3 inhibitor:   0.715 BCRP inhibitor:   0.018
BSEP inhibitor:   0.999

ADMET: Metabolism

CYP1A2-inhibitor:   0.009 CYP1A2-substrate:   0.009
CYP2C19-inhibitor:   0.431 CYP2C19-substrate:   0.103
CYP2C9-inhibitor:   0.004 CYP2C9-substrate:   0.119
CYP2D6-inhibitor:   0.014 CYP2D6-substrate:   0.017
CYP3A4-inhibitor:   0.999 CYP3A4-substrate:   0.641
CYP2B6-substrate:   0.0 CYP2C8-inhibitor:   1.0
HLM stability:   0.27
?
Human liver microsomal (HLM) stability. Category 0: stable+ (HLM > 30 min); Category 1: unstable- (HLM ≤ 30 min). The output value is the probability of human liver microsomal instability, where a value closer to 1 indicates a higher likelihood of instability.

ADMET: Excretion

Clearance (CL):  8.74 Half-life (T1/2):  0.622

ADMET: Toxicity

hERG Blockers:  0.04 hERG Blockers (10um):  0.223
Human Hepatotoxicity (H-HT):  0.489 Drug-induced Liver Injury (DILI):  0.29
AMES Toxicity:  0.433 Rat Oral Acute Toxicity:  0.257
Maximum Recommended Daily Dose:  0.291 Skin Sensitization:  0.932
Carcinogencity:  0.792 Eye Corrosion:  0.007
Eye Irritation:  0.317 Respiratory Toxicity:  0.255
Drug-induced Neurotoxicity:  0.025 Ototoxicity:  0.651
Hematotoxicity:  0.542 Drug-induced Nephrotoxicity:  0.525
Genotoxicity:  0.328 RPMI-8226 Immunitoxicity:  0.046
A549 Cytotoxicity:  0.115 Hek293 Cytotoxicity:  0.117
BCF:   1.142
?
Bioconcentration factors are used for considering secondary poisoning potential and assessing risks to human health via the food chain. The unit is -log10[(mg/L)/(1000*MW)].
IGC50:   4.196
?
48 hour Tetrahymena pyriformis IGC50. The unit of IGC50 is -log10[(mg/L)/(1000*MW)].
LC50DM:   5.995
?
48 hour Daphnia magna LC50. The unit of LC50DM is -log10[(mg/L)/(1000*MW)].
LC50FM:   5.229
?
96 hour fathead minnow LC50. The unit of LC50FM is -log10[(mg/L)/(1000*MW)].

  Species Source

Organism ID Organism Name Taxonomy Level Family SuperKingdom Isolation Part Collection Location Collection Time Reference
NPO33335 Jaspis sp. Species Ancorinidae Eukaryota n.a. Vanuatu islands n.a. PMID[10924170]
NPO33335 Jaspis sp. Species Ancorinidae Eukaryota n.a. n.a. n.a. PMID[11277766]
NPO33335 Jaspis sp. Species Ancorinidae Eukaryota n.a. depth of 25 m off the shore of Keomun Island, Korea 2004-AUG PMID[18407691]
NPO33335 Jaspis sp. Species Ancorinidae Eukaryota n.a. n.a. n.a. PMID[18990572]
NPO33335 Jaspis sp. Species Ancorinidae Eukaryota n.a. n.a. n.a. PMID[8326327]
NPO33335 Jaspis sp. Species Ancorinidae Eukaryota n.a. n.a. n.a. Database[COCONUT]

Note for Reference:
In addition to directly collecting NP source organism data from primary literature (where reference will provided as NCBI PMID or DOI links), NPASS also integrated them from below databases:
UNPD: Universal Natural Products Database [PMID: 23638153].
StreptomeDB: a database of streptomycetes natural products [PMID: 33051671].
TM-MC: a database of medicinal materials and chemical compounds in Northeast Asian traditional medicine [PMID: 26156871].
TCM@Taiwan: a Traditional Chinese Medicine database [PMID: 21253603].
TCMID: a Traditional Chinese Medicine database [PMID: 29106634].
TCMSP: The traditional Chinese medicine systems pharmacology database and analysis platform [PMID: 24735618].
HerDing: a herb recommendation system to treat diseases using genes and chemicals [PMID: 26980517].
MetaboLights: a metabolomics database [PMID: 27010336].
FooDB: a database of constituents, chemistry and biology of food species [www.foodb.ca].



  NP Quantity Composition/Concentration

Organism ID Organism Name Organism Material Preparation Organism Part NP Quantity (Standard) NP Quantity (Minimum) NP Quantity (Maximum) Quantity Unit Reference

Note for Reference:
In addition to directly collecting NP quantitative data from primary literature (where reference will provided as NCBI PMID or DOI links), NPASS also integrated NP quantitative records for specific NP domains (e.g., NPS from foods or herbs) from domain-specific databases. These databases include:
DUKE: Dr. Duke's Phytochemical and Ethnobotanical Databases.
PHENOL EXPLORER: is the first comprehensive database on polyphenol content in foods [PMID: 24103452], its homepage can be accessed at here.
FooDB: a database of constituents, chemistry and biology of food species [www.foodb.ca].



 Biological Activity

Molecular-level activity

Target ID Target Type Target Name Target Organism Activity Type Activity Relation Value Unit Reference

In vitro activity

Target ID Target Type Target Name Target Organism Activity Type Activity Relation Value Unit Reference
NPT375 Cell line Malme-3M Homo sapiens IC50 = 0.11 ug.mL-1 PMID[15787444]
NPT112 Cell line MOLT-4 Homo sapiens IC50 = 1.62 ug.mL-1 PMID[16643030]

In vivo activity

Target ID Target Type Target Name Target Organism Activity Type Activity Relation Value Unit Reference





 Experimental ADME

Experiment Model Experiment Tissue ADME Type ADME Relation ADME Value ADME Unit Reference





 Experimental Toxicity

Quantitative toxicity

Experiment Model Experiment Organism Toxicity Type Toxicity Relation Toxicity Value Toxicity Unit Reference

Common Abbreviations:
LC: Lethal Concentration; LD: Lethal Dose; LT:Lethal Time; NOAEL: No-observed-adverse-effect Level; BMDL: Benchmark Dose Lower Confidence Limit; BMD: Benchmark Dose; BMC:Benchmark Concentration; LOAEL: Lowest Observed Adverse Effect Level; RfD:Reference Dose; RfC:Reference Concentration; MRL: Minimal Risk Level; MEG: Maximum Exposure Guideline; PAC: Protective Action Criteria

Categorical toxicity labels

Hepatotoxicity Carcinogenicity Mutagenicity Cardiotoxicity Respiratory Toxicity Eye Irritation Endocrine Disruption
Hepatotoxicity Carcinogenicity Mutagenicity Cardiotoxicity Respiratory Toxicity Eye Irritation Endocrine Disruption

Note for Reference:
In addition to directly collecting NP quantitative data from primary literature (where reference will provided as NCBI PMID or DOI links), NPASS also integrated NP toxicity records from domain-specific databases. These databases include:
ToxValDB: a curated database that compiles quantitative toxicity values for chemicals from diverse public sources to support toxicological research and risk assessment.
TOXRIC: a comprehensive, free-to-access, online database providing toxicological/feature data. The toxicity labels are retrieved from this database. [PMID: 36400569]


  Chemically structural similarity

Similar Active Natural Products in NPASS

Top-200 similar NPs were calculated against the active-NP-set (includes approximately 50,000 NPs with experimentally-derived bioactivity available in NPASS)

Similarity is measured using the Tanimoto coefficient (Tc) , which compares the binary fingerprints of two molecules. Tc is calculated as the intersection divided by the union of '1' bits in the fingerprints, ranging from 0 to 1, with 1 indicating highest similarity.

●  The left chart: Distribution of similarity level between NPC115899 and all remaining natural products in the NPASS database.
●  The right table: Most similar natural products (Tc>=0.5 or Top200).

Similarity Score Similarity Level Natural Product ID
0.8438 Intermediate Similarity NPC266955
0.75 Intermediate Similarity NPC155332
0.75 Intermediate Similarity NPC114540
0.6912 Remote Similarity NPC474690
0.5972 Remote Similarity NPC473435
0.5972 Remote Similarity NPC473280
0.5972 Remote Similarity NPC471078
0.5915 Remote Similarity NPC151725
0.5789 Remote Similarity NPC473284
0.5789 Remote Similarity NPC32577
0.5733 Remote Similarity NPC110937
0.5694 Remote Similarity NPC474842
0.5694 Remote Similarity NPC475965
0.5694 Remote Similarity NPC604299
0.56 Remote Similarity NPC106425
0.56 Remote Similarity NPC122324
0.56 Remote Similarity NPC605871
0.5584 Remote Similarity NPC473482
0.5513 Remote Similarity NPC473283
0.5513 Remote Similarity NPC475526
0.5476 Remote Similarity NPC473617
0.5476 Remote Similarity NPC473828
0.5278 Remote Similarity NPC2049
0.5205 Remote Similarity NPC310752
0.5195 Remote Similarity NPC6206
0.5132 Remote Similarity NPC292491
0.5128 Remote Similarity NPC10064
0.5128 Remote Similarity NPC170221
0.5067 Remote Similarity NPC141292

Similar Clinical/Approved Drugs

Similarity level is defined by Tanimoto coefficient (Tc) between two molecules.

●  The left chart: Distribution of similarity level between NPC115899 and all drugs/candidates.
●  The right table: Most similar clinical/approved drugs (Tc>=0.5 or Top200).

Similarity Score Similarity Level Drug ID Developmental Stage
NPD

Bioactivity similarity

  Bioactivity similarity

Similar Natural Products in NPASS

Similarity level is defined by Bioactivity similarity was calculated based on bioactivity descriptors of compounds. The bioactivity descriptors were calculated by a recently developed AI algorithm Chemical Checker (CC) [Nature Biotechnology, 38:1087–1096, 2020; Nature Communications, 12:3932, 2021], which evaluated bioactivity similarities at five levels:
A: chemistry similarity;
B: biological targets similarity;
C: networks similarity;
D: cell-based bioactivity similarity;
E: similarity based on clinical data.
Those 5 categories of CC bioactivity descriptors were calculated and then subjected to manifold projection using UMAP algorithm, to project all NPs on a 2-Dimensional space. The current NP was highlighted with a small circle in the 2-D map. Below figures: left-to-right, A-to-E.

A: chemistry similarity
B: biological targets similarity
C: networks similarity
D: cell-based bioactivity similarity
E: similarity based on clinical data